Cite
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events.
MLA
Long He, et al. “Pharmacovigilance Study of GLP-1 Receptor Agonists for Metabolic and Nutritional Adverse Events.” Frontiers in Pharmacology, July 2024, pp. 01-13. EBSCOhost, https://doi.org/10.3389/fphar.2024.1416985.
APA
Long He, Qiuyu Li, Yongfeng Yang, Jiahao Li, Wei Luo, Yilan Huang, & Xiaoyan Zhong. (2024). Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events. Frontiers in Pharmacology, 01-13. https://doi.org/10.3389/fphar.2024.1416985
Chicago
Long He, Qiuyu Li, Yongfeng Yang, Jiahao Li, Wei Luo, Yilan Huang, and Xiaoyan Zhong. 2024. “Pharmacovigilance Study of GLP-1 Receptor Agonists for Metabolic and Nutritional Adverse Events.” Frontiers in Pharmacology, July, 01-13. doi:10.3389/fphar.2024.1416985.